The R&D Tax Incentive is a backward-looking instrument. The work happens through the income year, the registration is lodged within ten months of year-end, and the cash refund or offset arrives some time after the company's tax return is processed.

From the day the first eligible expenditure is incurred to the day the refund is in the bank account, it's not unusual for eighteen months to pass. For a company actively spending against the work, that's eighteen months of negative cash flow against a known future receivable.

The mechanics for funding that gap have matured significantly in the past five years. The instrument is debt against forecast R&D refunds, and it's now a meaningful capital category for Australian R&D-active companies.

How the facility works

The structure is straightforward. A specialist lender advances cash against the company's forecast R&D refund, typically as a senior secured facility. The advance is sized as a percentage of the projected refund (commonly 70–85%), drawn at a discount rate that reflects the lender's cost of capital plus a margin for the risk that the refund comes in below forecast.

On lodgement and refund receipt, the lender is repaid first from the ATO refund proceeds. Any residual flows to the company.

The mechanic is conceptually similar to invoice finance, applied to a regulatory receivable rather than a commercial one.

What comfort letters do

The critical input from the company's R&D consulting firm is a comfort letter. The comfort letter sets out, on the firm's letterhead:

  • The methodology used to forecast the refund.
  • The eligibility position taken on the underlying R&D activities.
  • The expenditure assumptions, with sensitivity to the main variables.
  • Any flagged risks (eligibility, apportionment, contractor mix, overseas activities) that could affect the refund.
  • The firm's view on the reasonable range the refund should fall within.

The comfort letter is not an audit, not a guarantee, and not a tax opinion. It's a structured statement of the consulting firm's reasonable expectation, on the basis of work it has actually undertaken. Lenders use it to underwrite the facility. Companies use it to set the conversation with the lender on a defensible footing.

The quality of the comfort letter directly affects the advance rate, the discount applied, and how quickly the facility closes.

What lenders look for

The lenders active in this market have converged on a common set of underwriting inputs:

  1. A history of successful claims. First-time claimants are harder to finance — the lender has no track record of refund actualisation to anchor the forecast.
  2. A consulting firm doing the work. Self-prepared claims, however accurate, are harder to underwrite. Lenders prefer to see an external firm with skin in the methodology.
  3. Clean eligibility positions. Aggressive claims with material overseas activity, related-party expenditure, or unresolved ATO queries are either declined or financed at materially worse terms.
  4. Stable corporate structure. Lenders want to see the entity that incurred the expenditure is the entity that will receive the refund, with no restructuring planned.
  5. Predictable expenditure run rate. Spiky or front-loaded R&D spend complicates the forecast. Steady expenditure makes underwriting easier.

When debt against the refund makes sense

Debt against forecast refunds is not the cheapest form of capital available, and it shouldn't be the first choice for every company. It does make sense when:

  • The work is happening and needs funding now, not eighteen months from now.
  • The company has a multi-year R&D programme in flight and can demonstrate continuity of refund receipts.
  • Equity is materially more expensive (most early-stage situations).
  • Bank debt isn't available against the underlying R&D activity itself.
  • The cash deployment generates a return materially above the debt cost.

It doesn't make sense when the refund is a one-off, when the underlying eligibility is unsettled, or when the company has cheaper sources of capital available.

The structural position

Specialist R&D refund lenders in Australia have evolved into a recognisable category. They are not banks, they price for the risk they're underwriting, and they want to see disciplined claim preparation behind every facility. The conversation between the company, the consulting firm and the lender is most productive when the consulting firm's work is structured for the lender's underwriting from the start, not retrofitted at the point a facility is being negotiated.

For companies running a continuous R&D programme, building the documentation to facility-grade is now standard operating procedure. The cost is marginal. The capital optionality it preserves is material.